{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:13:53Z","timestamp":1783548833479,"version":"3.55.0"},"reference-count":51,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,12,1]]},"DOI":"10.5551\/jat.64000","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T22:13:36Z","timestamp":1684793616000},"page":"1838-1848","source":"Crossref","is-referenced-by-count":4,"title":["Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes"],"prefix":"10.5551","volume":"30","author":[{"given":"Yuka","family":"Natsuki","sequence":"first","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kakutani","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kurajoh","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine"},{"name":"Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"},{"name":"Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S and Yamashita T: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A, 2001; 98: 6500-6505","DOI":"10.1073\/pnas.101545198"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E and Nishizawa Y: FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int, 2004; 65: 1943-1946","DOI":"10.1111\/j.1523-1755.2004.00604.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB and Wolf M: Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int, 2011; 79: 1370-1378","DOI":"10.1038\/ki.2011.47"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gao S, Xu J, Zhang S and Jin J: Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients. Blood Purif, 2019; 47 Suppl 1: 24-30","DOI":"10.1159\/000496220"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M and Investigators H: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol, 2011; 22: 1913-1922","DOI":"10.1681\/ASN.2010121224"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, Landray MJ, Moe SM, Yang J, Holland L, di Giuseppe R, Bouma-de Krijger A, Mihaylova B and Herrington WG: Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis. J Am Soc Nephrol, 2018; 29: 2015-2027","DOI":"10.1681\/ASN.2017121334"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Xiao Y, Luo X, Huang W, Zhang J and Peng C: Fibroblast growth factor 23 and risk of all-cause mortality and cardiovascular events: a meta-analysis of prospective cohort studies. Int J Cardiol, 2014; 174: 824-828","DOI":"10.1016\/j.ijcard.2014.04.138"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hu X, Ma X, Luo Y, Xu Y, Xiong Q, Pan X, Bao Y and Jia W: Contribution of fibroblast growth factor 23 to Framingham risk score for identifying subclinical atherosclerosis in Chinese men. Nutr Metab Cardiovasc Dis, 2017; 27: 147-153","DOI":"10.1016\/j.numecd.2016.11.009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, Lima JA, Polak JF, Blondon M, Ruzinski J, Rock D and de Boer IH: Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail, 2014; 7: 409-417","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hsu JJ, Katz R, Ix JH, de Boer IH, Kestenbaum B and Shlipak MG: Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant, 2014; 29: 2099-2105","DOI":"10.1093\/ndt\/gfu101"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mirza MA, Larsson A, Lind L and Larsson TE: Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis, 2009; 205: 385-390","DOI":"10.1016\/j.atherosclerosis.2009.01.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) van der Vaart A, Yeung SMH, van Dijk PR, Bakker SJL and de Borst MH: Phosphate and fibroblast growth factor 23 in diabetes. Clin Sci (Lond), 2021; 135: 1669-1687","DOI":"10.1042\/CS20201290"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yoda K, Imanishi Y, Yoda M, Mishima T, Ichii M, Yamada S, Mori K, Emoto M and Inaba M: Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis. J Clin Endocrinol Metab, 2012; 97: E2036-2043","DOI":"10.1210\/jc.2012-2024"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wahl P, Xie H, Scialla J, Anderson CAM, Bellovich K, Brecklin C, Chen J, Feldman H, Gutierrez OM, Lash J, Leonard MB, Negrea L, Rosas SE, Anderson AH, Townsend RR, Wolf M, Isakova T and Group obotCRICS: Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease. Diabetes Care, 2012; 35: 994-1001","DOI":"10.2337\/dc11-2235"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Silva AP, Mendes F, Carias E, Gon\u00e7alves RB, Fragoso A, Dias C, Tavares N, Caf\u00e9 HM, Santos N, Rato F, Le\u00e3o Neves P and Almeida E: Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients. Int J Mol Sci, 2019; 20:","DOI":"10.3390\/ijms20071536"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tu\u00f1\u00f3n J, Fern\u00e1ndez-Fern\u00e1ndez B, Carda R, Pello AM, Crist\u00f3bal C, Tar\u00edn N, Ace\u00f1a \u00c1, Gonz\u00e1lez-Casaus ML, Huelmos A, Alonso J, Lorenzo \u00d3, Gonz\u00e1lez-Parra E, Hern\u00e1ndez-Gonz\u00e1lez I, Mah\u00edllo-Fern\u00e1ndez I, L\u00f3pez-Besc\u00f3s L and Egido J: Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease. Diabetes Metab Res Rev, 2016; 32: 685-693","DOI":"10.1002\/dmrr.2787"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yeung SMH, Binnenmars SH, Gant CM, Navis G, Gansevoort RT, Bakker SJL, de Borst MH and Laverman GD: Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function. Diabetes Care, 2019; 42: 2151-2153","DOI":"10.2337\/dc19-0528"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tomiyama H and Yamashina A: Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J, 2010; 74: 24-33","DOI":"10.1253\/circj.CJ-09-0534"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Maruhashi T, Kajikawa M, Kishimoto S, Hashimoto H, Takaeko Y, Yamaji T, Harada T, Han Y, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A and Higashi Y: Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery. J Am Heart Assoc, 2020; 9: e013915","DOI":"10.1161\/JAHA.119.013915"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) American Diabetes Association: Standards of medical care in diabetes--2014. Diabetes Care, 2014; 37 Suppl 1: S14-80","DOI":"10.2337\/dc14-S014"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M and Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig, 2010; 1: 212-228","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hayashi M, Morioka T, Hatamori M, Kakutani Y, Yamazaki Y, Kurajoh M, Motoyama K, Mori K, Fukumoto S, Shioi A, Shoji T, Emoto M and Inaba M: Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk. Diabetes Res Clin Pract, 2019; 148: 160-168","DOI":"10.1016\/j.diabres.2019.01.009"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A and Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T and Fukumoto S: Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab, 2002; 87: 4957-4960","DOI":"10.1210\/jc.2002-021105"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J and Vogel R: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002; 39: 257-265","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Inoue T, Matsuoka H, Higashi Y, Ueda S, Sata M, Shimada KE, Ishibashi Y and Node K: Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res, 2008; 31: 2105-2113","DOI":"10.1291\/hypres.31.2105"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kawano N, Emoto M, Mori K, Yamazaki Y, Urata H, Tsuchikura S, Motoyama K, Morioka T, Fukumoto S, Shoji T, Koyama H, Okuno Y, Nishizawa Y and Inaba M: Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients. J Atheroscler Thromb, 2012; 19: 276-284","DOI":"10.5551\/jat.10629"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Morioka T, Emoto M, Yamazaki Y, Kawano N, Imamura S, Numaguchi R, Urata H, Motoyama K, Mori K, Fukumoto S, Koyama H, Shoji T and Inaba M: Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes. Cardiovasc Diabetol, 2014; 13: 10","DOI":"10.1186\/1475-2840-13-10"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Imanishi Y, Kobayashi K, Kawata T, Inaba M and Nishizawa Y: Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases. Ther Apher Dial, 2007; 11 Suppl 1: S32-37","DOI":"10.1111\/j.1744-9987.2007.00519.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Larsson T, Nisbeth U, Ljunggren O, J\u00fcppner H and Jonsson KB: Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int, 2003; 64: 2272-2279","DOI":"10.1046\/j.1523-1755.2003.00328.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) S\u00f8rensen MH, Bojer AS, J\u00f8rgensen NR, Broadbent DA, Plein S, Madsen PL and G\u00e6de P: Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics. Cardiovasc Diabetol, 2020; 19: 158","DOI":"10.1186\/s12933-020-01135-z"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M and Zoccali C: FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int, 2010; 78: 679-685","DOI":"10.1038\/ki.2010.194"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Guo LW, Wang YK, Li SJ, Yin GT and Li D: Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-\u03baB Signaling Pathway. J Atheroscler Thromb, 2023; 30: 138-149","DOI":"10.5551\/jat.63460"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Richter B, Haller J, Haffner D and Leifheit-Nestler M: Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Pflugers Arch, 2016; 468: 1621-1635","DOI":"10.1007\/s00424-016-1858-x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Silswal N, Touchberry CD, Daniel DR, McCarthy DL, Zhang S, Andresen J, Stubbs JR and Wacker MJ: FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am J Physiol Endocrinol Metab, 2014; 307: E426-436","DOI":"10.1152\/ajpendo.00264.2014"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Li Y, Cui R, Liu K, Eshak ES, Cui M, Dong J, Imano H, Muraki I, Kiyama M, Kitamura A, Okada T, Yamagishi K, Umesawa M, Ohira T and Iso H: Relationship between Endothelial Dysfunction and Prevalence of Chronic Kidney Disease: The Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb, 2021; 28: 622-629","DOI":"10.5551\/jat.56424"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Zoccali C: Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol, 2006; 17: S61-63","DOI":"10.1681\/ASN.2005121344"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Donate-Correa J, Mora-Fernandez C, Martinez-Sanz R, Muros-de-Fuentes M, Perez H, Meneses-Perez B, Cazana-Perez V and Navarro-Gonzalez JF: Expression of FGF23\/KLOTHO system in human vascular tissue. Int J Cardiol, 2013; 165: 179-183","DOI":"10.1016\/j.ijcard.2011.08.850"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Chen PY, Qin L, Li G, Tellides G and Simons M: Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF\u03b2)-dependent smooth muscle cell phenotype modulation. Sci Rep, 2016; 6: 33407","DOI":"10.1038\/srep33407"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Qi M and Xin S: FGF signaling contributes to atherosclerosis by enhancing the inflammatory response in vascular smooth muscle cells. Mol Med Rep, 2019; 20: 162-170","DOI":"10.3892\/mmr.2019.10249"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Six I, Okazaki H, Gross P, Cagnard J, Boudot C, Maizel J, Drueke TB and Massy ZA: Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. PLoS One, 2014; 9: e93423","DOI":"10.1371\/journal.pone.0093423"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Gutierrez OM, Wolf M and Taylor EN: Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol, 2011; 6: 2871-2878","DOI":"10.2215\/CJN.02740311"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y and Takeda E: Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol, 2009; 20: 1504-1512","DOI":"10.1681\/ASN.2008101106"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Giachelli CM: The emerging role of phosphate in vascular calcification. Kidney Int, 2009; 75: 890-897","DOI":"10.1038\/ki.2008.644"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H and Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000; 87: E10-17","DOI":"10.1161\/01.RES.87.7.e10"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Zhou C, He Q, Gan H, Zeng T, Liu Q, Moorhead JF, Varghese Z, Ouyang N and Ruan XZ: Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans. Kidney Int, 2021; 99: 1342-1353","DOI":"10.1016\/j.kint.2021.01.016"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Disthabanchong S: Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification. Int J Nephrol, 2018; 2018: 3162806","DOI":"10.1155\/2018\/3162806"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Kuro-o M: Phosphate as a Pathogen of Arteriosclerosis and Aging. J Atheroscler Thromb, 2021; 28: 203-213","DOI":"10.5551\/jat.RV17045"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Mencke R, van der Vaart A, Pasch A, Harms G, Waanders F, Bilo HJG, van Goor H, Hillebrands JL and van Dijk PR: Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus. BMJ Open Diabetes Res Care, 2021; 9:","DOI":"10.1136\/bmjdrc-2020-002016"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Rostand SG and Dr\u00fceke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int, 1999; 56: 383-392","DOI":"10.1046\/j.1523-1755.1999.00575.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Natsuki Y, Morioka T, Fukumoto S, Kakutani Y, Yamazaki Y, Ochi A, Kurajoh M, Mori K, Shoji T, Imanishi Y, Inaba M and Emoto M: Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney function. Endocr J, 2022; 69: 121-129","DOI":"10.1507\/endocrj.EJ21-0185"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/12\/30_64000\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:55:50Z","timestamp":1715576150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/12\/30_64000\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64000","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"article-number":"64000"}}